Miller, J. E., Taylor‐Cousar, J. L., Overdevest, J. B., Khatiwada, A., Mace, J. C., Alt, J. A., Bodner, T. E., Chowdhury, N. I., DiMango, E. A., Eshaghian, P. H., Getz, A. E., Gudis, D. A., Han, E. J., Hwang, P. H., Keating, C. L., Khanwalkar, A., Kimple, A. J., Lee, J. T., Li, D., … Beswick, D. M. (2023). Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy. International Forum of Allergy & Rhinology, 14(6), 1079–1087. Portico. https://doi.org/10.1002/alr.23312
Subjects:
Cystic Fibrosis
(MeSH)
Aminophenols
(MeSH)
Indoles
(MeSH)
Benzodioxoles
(MeSH)
Olfaction Disorders
(MeSH)
Publication Type:
Article
Unique ID:
10.1002/alr.23312
PMID:
DOI:
Publication Date:
Data Source:
PubMed
Source Link: